Assessing and treating insulin resistance in women with polycystic ovarian syndrome - Test2 - elhamkhani - TriplyDB

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

http://www.wikidata.org/entity/Q34878055

about

Mixed form of hirsutism in an adolescent female and laser therapy.Association study of gene LPP in women with polycystic ovary syndrome Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats.Defining the role of bariatric surgery in polycystic ovarian syndrome patients.Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome.Association of common variants of FTO in women with polycystic ovary syndrome.Association of single-nucleotide polymorphisms rs2197076 and rs2241883 of FABP1 gene with polycystic ovary syndrome Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study.Assessment of the body composition of patients with polycystic ovary syndrome using dual-energy X-ray absorptiometry.Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial.The role of hyperinsulinemia as a cardiometabolic risk factor independent of obesity in polycystic ovary syndrome.

P2860

Q33918371-E7C00F0F-FB59-4E2A-88FA-58F2956C79BC Q34441368-BBA4265D-0C72-4827-89D6-B60FB7485A28 Q35527825-6C09DB1C-4462-4171-887A-7B3B07BB1917 Q35753559-0F126884-6E84-482F-B27B-26DB6B3EDA91 Q35906974-A9CD0353-4C7A-427A-B381-C29AE4A67F47 Q36076094-36D2A818-81C5-4D77-B7DF-E84460118F90 Q36375557-0BFCC295-84BC-4983-80A0-DFB5D13C55BE Q36474781-A0B3F650-59EE-48C9-8EF9-A6D08717A3BD Q36732197-34FB324D-DBAC-4083-A603-CF7FD38DEB1B Q36837104-10A9B9BA-7315-464A-BD4E-C9296786A528 Q47583268-F6B51400-B65A-4921-BE04-68D2F98B394A Q48102672-DBF55D54-BDBC-4C5E-A53B-0C81123E7A38 Q53775943-4C281013-6BB4-4F74-9AD5-D295F6EC3A3D

P2860

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

http://www.wikidata.org/entity/Q34878055

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@ast

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@en

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@nl

type

label

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@ast

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@en

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@nl

prefLabel

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@ast

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@en

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@nl

P1433

Q34878055-520F6A20-6DAE-41C7-A4B0-1AE7FFC426D0

P1476

Q34878055-104D636B-F554-4FC3-BE29-7AA43A75E944

P2093

Q34878055-ECFFC4A0-0BE1-4920-860F-3B92215F43DD

P2860

Q34878055-02EE604B-B621-4320-9835-3A7175AA5A94

Q34878055-06DA52CB-AB0A-4325-B679-106DB0B23DDB

Q34878055-07541A08-FB95-46EE-8CDC-6E186D835249

Q34878055-0AEDA287-DE65-4C10-9D6D-B276C3A0BE88

Q34878055-10A17EBD-4ACD-4578-8A47-2F2C44346DA8

Q34878055-16516BDB-C0AB-4AAB-9FB4-9E7C770CC153

Q34878055-178C126C-8D57-4FC8-82E1-853833E9D60E

Q34878055-193F78B0-E54F-4349-BBE6-7A6368FEBFF0

Q34878055-1B6D557A-0EC8-4909-AA27-8CA9071091BC

Q34878055-1BCDC04A-139B-4D99-AA46-335D7F9C6434

P304

Q34878055-451873F2-0901-463B-B6EA-9B194B14A77B

P31

Q34878055-19F991DD-2AA9-4A1C-861D-5D70676A97AA

Q34878055-fd4e62a5-84cc-4f0b-9184-c12772caa989

P356

Q34878055-20F910A2-F5F8-4C36-8075-260F94F4DDBD

P433

Q34878055-A80139B6-DC70-4CB6-BFDF-0119CF9A0F53

P478

Q34878055-3A232B11-441B-47AD-B6E9-E37B3DD44E58

P577

Q34878055-E6A2CDD7-43B9-49CD-ADDC-C314535DE5DE

P5875

Q34878055-48583C2A-7347-4768-8B58-90B7585D341D

P698

Q34878055-9FDAC618-D3BE-4464-887E-EE6BCACF4B6F

P921

Q34878055-319DE52B-F254-4E69-BCAE-89697933F5F6

P932

Q34878055-95D7795A-6714-4912-909D-550DE583C643

P356

P1433

World journal of diabetes

P1476

Assessing and treating insulin resistance in women with polycystic ovarian syndrome

@en

P2093

Michael L Traub

http://www.w3.org/2001/XMLSchema#string

P2860

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).

Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells.

Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.

Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females

Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome.

Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome.

Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome

P304

33-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4239/WJD.V2.I3.33

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51093440

http://www.w3.org/2001/XMLSchema#string

P698

21537458

http://www.w3.org/2001/XMLSchema#string

P921

P932

3083905

http://www.w3.org/2001/XMLSchema#string